Michael Newman

Insider Reports History

Entity
Individual
Location
C/O Intec Parent, Inc., 12 Hartom St., Har Hotzvim, Jerusalem, Israel
Signature
/s/ Michael Newman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Newman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Indaptus Therapeutics, Inc. CSO and Director, Director, 10%+ Owner Stock Option (Right to Buy) 75K Oct 9, 2024 Direct

Insider Reports Filed by Michael Newman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INDP Indaptus Therapeutics, Inc. Oct 9, 2024 1 $0 4 Oct 10, 2024 CSO and Director, Director, 10%+ Owner
INDP Indaptus Therapeutics, Inc. Jan 22, 2024 1 $0 4 Jan 23, 2024 CSO and Director, Director, 10%+ Owner
INDP Indaptus Therapeutics, Inc. Jan 18, 2023 1 $0 4 Jan 20, 2023 CSO and Director, Director, 10%+ Owner
INDP Indaptus Therapeutics, Inc. Jan 31, 2022 2 -$100K 4 Feb 2, 2022 CSO and Director, Director, 10%+ Owner
INDP Indaptus Therapeutics, Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 CSO and Director, Director, 10%+ Owner
INDP Indaptus Therapeutics, Inc. Aug 4, 2021 1 $0 4 Aug 6, 2021 CSO and Director, Director, 10%+ Owner
INDP Indaptus Therapeutics, Inc. Aug 3, 2021 0 $0 3 Aug 6, 2021 Chief Scientific Officer, Director, 10%+ Owner